Tibet Cheezheng Tibetan Medicine Co., Ltd.

Equities

002287

CNE100000FM9

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-11 pm EDT 5-day change 1st Jan Change
21.21 CNY -0.52% Intraday chart for Tibet Cheezheng Tibetan Medicine Co., Ltd. -3.24% -5.69%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tibet Cheezheng Tibetan Medicine's Profit Rises 29.5% in 2023; Shares Up 5% MT
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on July 20, 2023 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Approves Cash Dividend for the Year 2022 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Tibet Cheezheng Tibetan Medicine Logs 34.1% Drop in 2022 Profit MT
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Announces Final Cash Dividend on A Shares for 2021, Payable on 19 July 2022 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Approves Cash Dividend for the Financial Year 2021 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Proposes Final Cash Dividend for the Year 2021 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Announces Final Distribution on A Shares for the Year 2020, Payable on July 8, 2021 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Approves Cash Dividend for the Year 2020 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Announces Final Dividend for 2020 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Gansu Foge Tibetan Medicine Co., Ltd. announced that it expects to receive CNY 790.500216 million in funding from Tibet Cheezheng Tibetan Medicine Co., Ltd. and other investors CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd.(XSEC:002287) added to FTSE All-World Index CI
Chart Tibet Cheezheng Tibetan Medicine Co., Ltd.
More charts
Tibet Cheezheng Tibetan Medicine Co., Ltd is a China-based company, principally engaged in the research, development, manufacture and distribution of Tibetan medicines. The Company primarily offers medicines under emplastrum, ointment, granule, crude drugs and others. The Company's products include external pain relieving series, including Cheezheng Xiaotong emplastrum, Qingpeng ointment and Baimai ointment, as well as oral medicine series. The Company distributes its products within domestic market and to overseas markets.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 002287 Stock
  4. News Tibet Cheezheng Tibetan Medicine Co., Ltd.
  5. Tibet Cheezheng Tibetan Medicine's Profit Rises 29.5% in 2023; Shares Up 5%